Hans Klingemann

Hans Klingemann

Chief Tech/Sci/R&D Officer chez IMMUNITYBIO, INC.

74 ans
Health Technology
Consumer Services
Health Services

Profil

Hans Georg Klingemann was the founder of NantKwest, Inc. (founded in 2002) where he held the title of Director, Chief Medical & Scientific Officer from 2012 to 2015.
He is currently the Chief Science Officer–Cellular at ImmunityBio, Inc. Dr. Klingemann's former positions include being an Independent Non-Executive Director at Osiris Therapeutics, Inc. from 2012 to 2016, Director-Bone Marrow Transplant at Rush University Medical Center, Director at Bone Marrow & Cancer Foundation, Inc., and Director-Stem Cell Transplant at Tufts Medical Center, Inc.Dr. Klingemann obtained a doctorate degree from Philipps University of Marburg and the University of Würzburg Medical School.

Postes actifs de Hans Klingemann

SociétésPosteDébut
IMMUNITYBIO, INC. Chief Tech/Sci/R&D Officer -
Tous les postes actifs de Hans Klingemann

Anciens postes connus de Hans Klingemann

SociétésPosteFin
OSIRIS THERAPEUTICS, INC. Director/Board Member 11/06/2016
Corporate Officer/Principal -
Corporate Officer/Principal -
Director/Board Member -
IMMUNITYBIO, INC. Founder -
Voir l'expérience en détail de Hans Klingemann

Formation de Hans Klingemann

Philipps University of Marburg Doctorate Degree
University of Würzburg Medical School Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Hans Klingemann

Relations

35

Relations au 1er degré

8

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
IMMUNITYBIO, INC.

Health Technology

Entreprise privées5

Health Technology

Health Technology

Health Services

Commercial Services

Health Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Hans Klingemann